{"id":9566,"date":"2024-03-15T16:28:49","date_gmt":"2024-03-15T16:28:49","guid":{"rendered":"https:\/\/www.caltagmedsystems.co.uk\/information\/?p=9566"},"modified":"2024-03-15T16:28:50","modified_gmt":"2024-03-15T16:28:50","slug":"enhance-your-research-with-proscis-polyclonal-antibody-services","status":"publish","type":"post","link":"https:\/\/www.caltagmedsystems.co.uk\/information\/enhance-your-research-with-proscis-polyclonal-antibody-services\/","title":{"rendered":"Enhance your Research with ProSci\u2019s Polyclonal Antibody Services"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">What are Polyclonal Antibodies?<\/h2>\n\n\n\n<p>Polyclonal antibodies are a mixture of antibodies\u00a0from multiple B-cell clones of a host animal\u00a0that\u00a0can\u00a0recognise multiple epitopes on an antigen. Their unique\u00a0binding characteristic to different epitopes can help amplify their signal,\u00a0leading to increased sensitivity and better detection. Unlike monoclonal antibodies, created by selecting a single B-cell clone, polyclonal antibodies\u00a0occur naturally\u00a0through the immune response. Numerous applications, including Western Blot, ELISA, immunohistochemistry, and immunoprecipitation,\u00a0can be carried out using polyclonal antibodies. Polyclonal antibody therapeutics are also commonly\u00a0utilised\u00a0in medicine for virus and toxin neutralisation and immunoglobulin replacement therapy\u00a0(3). In diagnostics, polyclonal\u00a0antibodies\u00a0are\u00a0used\u00a0for pathology and lateral flow tests, among others.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><a href=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/image-159.png\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"512\" src=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/image-159.png\" alt=\"\" class=\"wp-image-9567\" style=\"width:610px;height:auto\" srcset=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/image-159.png 1024w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/image-159-300x150.png 300w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/image-159-768x384.png 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<p class=\"clear\">There are known limitations, such as limited supply and off-target binding of these antibodies.\u00a0New technologies\u00a0readily overcome these issues,\u00a0such as stringent validation procedures to\u00a0maximise lot-to-lot reproducibility. With\u00a0innovative\u00a0methods\u00a0available to overcome the limitations of polyclonal antibodies, they\u00a0remain\u00a0excellent cost-effective tools for researchers, diagnostic developers &amp; drug developers alike.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Benefits of Polyclonal Antibodies<\/h3>\n\n\n\n<ul class=\"wp-block-list\" style=\"font-size:16px\">\n<li>Clonal Properties:\n<ul class=\"wp-block-list\">\n<li>Due to their ability to detect several target protein epitopes,&nbsp;polyclonal&nbsp;antibodies have a high sensitivity to the target protein.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>Biophysical Diversity:\n<ul class=\"wp-block-list\">\n<li>Polyclonal antibodies are more stable than other antibodies when environmental factors cause other antibodies\u2019 inactivation, lability, or precipitation.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>Provides researchers with modification opportunities, including:\n<ul class=\"wp-block-list\">\n<li>Host species.<\/li>\n\n\n\n<li>Antigen quantity.<\/li>\n\n\n\n<li>Amount and distribution of injection sites.<\/li>\n\n\n\n<li>Antigen injection frequency.<\/li>\n\n\n\n<li>Adjuvant type.<\/li>\n\n\n\n<li>Adjuvant quantity.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>Quicker Production timeline.<\/li>\n\n\n\n<li>Development and production are done in\u00a0parallel.<\/li>\n\n\n\n<li>Competitive pricing.<\/li>\n<\/ul>\n\n\n\n<p>Check out the complete catalogue of\u00a0<a href=\"https:\/\/www.caltagmedsystems.co.uk\/pricing_ordering\/index.php?group_1=All&amp;group_2=All&amp;supplier=69&amp;clonality=2&amp;host=All&amp;species=All&amp;applications=All&amp;regulatory_status=All&amp;searchwords=\" target=\"_blank\" rel=\"noreferrer noopener\">polyclonal antibodies<\/a>\u00a0for various applications, from ProSci!<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Customise Your Research with Polyclonal Antibody Services!<\/h2>\n\n\n\n<p>ProSci&#8217;s service team can assist you with designing, purifying, and producing custom polyclonal antibodies.<\/p>\n\n\n\n<ul class=\"wp-block-list\" style=\"font-size:16px\">\n<li>Expertise\u00a0in immunogen determination and peptide design.<\/li>\n\n\n\n<li>Isolation of spleen and splenocytes to convert a rabbit polyclonal to\u00a0monoclonal.<\/li>\n\n\n\n<li>Provision of organs as a deliverable.<\/li>\n\n\n\n<li>Multiple\u00a0Ph.D. scientists\u00a0with specialised knowledge and experience.<\/li>\n\n\n\n<li>Exceptional customer service.<\/li>\n\n\n\n<li>Customisable deliverables tailored to meet specific\u00a0needs.<\/li>\n\n\n\n<li>Custom schedules are available to fit any\u00a0timeline.<\/li>\n<\/ul>\n\n\n\n<p>At\u00a0ProSci, these antibodies are generated in\u00a0various\u00a0host species from customised immunogens designed by expert antibody scientists. Their experts have years of experience designing antigens for small peptides, large proteins, small molecules, and special modifications such as\u00a0post-translational\u00a0modifications\u00a0(PTMs), including phosphorylation and glycosylation. They carefully pair antigen\u00a0designs\u00a0to host\u00a0animals, paying close attention to\u00a0your desired final\u00a0application to\u00a0maximise\u00a0success.\u00a0ProSci\u00a0offers Polyclonal Antibody Services in various custom configurations and standard packages, from Antigen Design\u00a0and\u00a0Synthesis to Immunisation to Production.\u00a0See their <a href=\"http:\/\/prosci-services.com\/polyclonal-antibody-services\/\">Polyclonal Antibody Services here<\/a>.<\/p>\n\n\n\n<p>Does your project require polyclonal antibodies? ProSci&#8217;s antibody experts and skilled project managers are dedicated to saving you time and costs and\u00a0optimising\u00a0your project to accelerate your next breakthrough. Partner with\u00a0ProSci\u00a0and research confidently.<\/p>\n\n\n\n<p>Caltag Medsystems is here to support you every step of the way through your custom project with ProSci.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-a89b3969 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-text-color has-background has-link-color wp-element-button\" href=\"https:\/\/www.caltagmedsystems.co.uk\/contact.php\" style=\"color:#fbc100;background-color:#21318f\" target=\"_blank\" rel=\"noreferrer noopener\">Contact us today to discuss your next project!<\/a><\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading clear\">References<\/h3>\n\n\n\n<ol class=\"wp-block-list\" style=\"font-size:16px\">\n<li>Bordeaux J, Welsh AW, Agarwal S, et al. Antibody validation.&nbsp;BioTechniques. 2010;48(3):197-209.&nbsp;doi:https:\/\/doi.org\/10.2144\/000113382<\/li>\n\n\n\n<li>Lipman NS, Jackson LR, Trudel LJ, Weis-Garcia F. Monoclonal Versus Polyclonal Antibodies: Distinguishing Characteristics, Applications, and Information Resources.&nbsp;ILAR Journal. 2005;46(3):258-268.&nbsp;doi:https:\/\/doi.org\/10.1093\/ilar.46.3.258<\/li>\n\n\n\n<li>Pelletier, J. P. R., &amp; Mukhtar, F. (2020). Passive Monoclonal and Polyclonal Antibody Therapies. Immunologic Concepts in Transfusion Medicine, 251\u2013348. https:\/\/doi.org\/10.1016\/B978-0-323-67509-3.00016-0<\/li>\n\n\n\n<li>Wootla, B., Denic, A., &amp; Rodriguez, M. (2014). Polyclonal and monoclonal antibodies in clinic. Methods in molecular biology (Clifton, N.J.), 1060, 79\u2013110. https:\/\/doi.org\/10.1007\/978-1-62703-586-6_5<\/li>\n<\/ol>\n\n\n\n<hr class=\"wp-block-separator has-text-color has-alpha-channel-opacity has-background\" style=\"background-color:#21318f;color:#21318f\"\/>\n\n\n\n<p>Information originally posted on:\u00a0<a href=\"https:\/\/prosci-services.com\/enhance-research-with-polyclonal-antibody-services\/?utm_source=ActiveCampaign&amp;utm_medium=email&amp;utm_content=ProSci+Blog%3A+%22The+Role+of+Monoclonal+Antibodies+%26+Biosimilars%22&amp;utm_campaign=ProSci+Blog+%22The+Power+of+Polyclonal+Antibodies%22+Select+Science\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/prosci-services.com\/enhance-research-with-polyclonal-antibody-services\/?utm_source=ActiveCampaign&amp;utm_medium=email&amp;utm_content=ProSci+Blog%3A+%22The+Role+of+Monoclonal+Antibodies+%26+Biosimilars%22&amp;utm_campaign=ProSci+Blog+%22The+Power+of+Polyclonal+Antibodies%22+Select+Science<\/a><\/p>\n\n\n\n<p>Caltag Medsystems is the distributor of&nbsp;<a href=\"https:\/\/www.caltagmedsystems.co.uk\/prosci\/\">ProSci&nbsp;<\/a>products in the UK &amp; Ireland. If you have any questions about these products, please&nbsp;<a href=\"https:\/\/www.caltagmedsystems.co.uk\/contact.php\">contact us<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>At ProSci, custom polyclonal antibodies are generated in various host species from customised immunogens designed by expert antibody scientists.<\/p>\n","protected":false},"author":13,"featured_media":8344,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[132,1,76],"tags":[185,78,437,77],"class_list":["post-9566","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-antibodies","category-general-information","category-services","tag-antibodies","tag-custom-antibody-service","tag-polyclonal-antibodies","tag-prosci"],"_links":{"self":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/9566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/comments?post=9566"}],"version-history":[{"count":4,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/9566\/revisions"}],"predecessor-version":[{"id":9571,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/9566\/revisions\/9571"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/media\/8344"}],"wp:attachment":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/media?parent=9566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/categories?post=9566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/tags?post=9566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}